VBIV

VBI Vaccines, Inc. New Common Stock (Canada)
VBIV

Overview Fund Activity
Delisted

VBIV was delisted on the 7th of August, 2024.

Back to rankings

131 hedge funds and large institutions have $83.3M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 44 reducing their positions, and 13 closing their positions.

Holders
131
Holders Change
–
Holders Change %
0%
% of All Funds
2.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
39
Reduced
44
Closed
13
Calls
$407K
Puts
$99K
Net Calls
+$308K
Net Calls Change
-$312K

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$1.44M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$638K
3
GCP
3
GSA Capital Partners
United Kingdom
$539K
4
BlackRock
4
BlackRock
New York
$11.1M
5
Qube Research & Technologies (QRT)
5
Qube Research & Technologies (QRT)
United Kingdom
$388K

Top Sellers

1
State Street
1
State Street
Massachusetts
$3.22M
2
UBS Group
2
UBS Group
Switzerland
$3K
3
Rafferty Asset Management
3
Rafferty Asset Management
New York
$42K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$3.55M
5
Bank of America
5
Bank of America
North Carolina
$220K
Name Market Value Shares Shares
Change 		Shares
Change %
PA
1
Perceptive Advisors
New York
$42.3M 52,335,002 – –
BlackRock
2
BlackRock
New York
$11.1M 13,707,702 +486,594 +4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$3.55M 4,392,854 -679,901 -13%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$3.33M 4,114,208 +184,632 +5%
State Street
5
State Street
Massachusetts
$3.22M 3,981,775 -12,235,036 -75%
Cambridge Investment Research Advisors
6
Cambridge Investment Research Advisors
Iowa
$1.81M 2,233,150 +43,450 +2%
GAI
7
General American Investors
New York
$1.52M 1,877,497 – –
Northern Trust
8
Northern Trust
Illinois
$1.51M 1,861,566 -28,958 -2%
Millennium Management
9
Millennium Management
New York
$1.44M 1,780,752 +1,209,393 +212%
Charles Schwab
10
Charles Schwab
California
$1.19M 1,471,457 -173,263 -11%
Goldman Sachs
11
Goldman Sachs
New York
$978K 1,209,507 +205,921 +21%
Renaissance Technologies
12
Renaissance Technologies
New York
$638K 789,500 +617,400 +359%
Nuveen Asset Management
13
Nuveen Asset Management
Illinois
$591K 731,209 -42,730 -6%
Invesco
14
Invesco
Georgia
$548K 677,832 +198,067 +41%
GCP
15
GSA Capital Partners
United Kingdom
$539K 667,059 +551,694 +478%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$538K 665,080 +5,200 +0.8%
FWM
17
Frontier Wealth Management
Missouri
$487K 601,800 – –
E
18
Ergoteles
New York
$456K 564,232 +347,154 +160%
Morgan Stanley
19
Morgan Stanley
New York
$429K 531,382 -449,276 -46%
Qube Research & Technologies (QRT)
20
Qube Research & Technologies (QRT)
United Kingdom
$388K 479,879 +390,984 +440%
Swiss National Bank
21
Swiss National Bank
Switzerland
$369K 456,200 +30,400 +7%
RJA
22
Raymond James & Associates
Florida
$349K 431,498 -245,018 -36%
Two Sigma Advisers
23
Two Sigma Advisers
New York
$311K 384,800 -77,000 -17%
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$266K 329,441 -85,279 -21%
Citadel Advisors
25
Citadel Advisors
Florida
$255K 315,393 +107,238 +52%
1
2 3 4 5